Epigeneres

Epigeneres is a biotech company in Mumbai, India, founded in 2008. It has raised $6.0M across 1 round, most recently a $6.0M Series B in December 2021.

Early cancer detection through epigenetic biomarker science

Headquarters
Mumbai
Employees
11–50
Founded
2008
Business Model
B2B
Total Funding
$6.0M
Last Round
$6.0M Series BDec 2021
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Epigeneres Biotech Private Limited is an Indian biotechnology company founded in 2008, focused on early cancer detection and stem cell research. The company co-developed a proprietary epigenetic cancer detection technology in collaboration with Singapore-based Tzar Labs, which uses HrC (Hematopoietic Regenerative Cells) biomarkers for non-invasive early cancer screening. Epigeneres holds a licensing agreement with Tzar Labs for the Indian territory. The company's diagnostic business has since been rebranded as Tzar Labs India, while Epigeneres continues research into pluripotent stem cells and maintains scientific collaborations with academic institutions.

Summary

It lists 11–50 employees. It has raised $6.0M in total across 1 round, most recently a $6.0M Series B round in Dec 2021. Investors include Kotak Investment Advisors.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BDec 2021
$6.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Epigeneres on Indexed.vc
<a href="https://indexed.vc/companies/epigeneres"><img src="https://indexed.vc/api/badge/company/epigeneres" alt="Epigeneres on Indexed.vc" width="260" height="76" /></a>